Konferenser och symposier

JIM Symposium: Human Models and Technology for Regenerative Medicine

2015-11-1909:00 till 2015-11-2017:15 Nobel Forum, Karolinska InstitutetCampus Solna

International symposium on stem cell biology, regenerative medicine and novel technologies.

Leading scientists in a number of research fields, including pancreas, cardiac, neural and liver biology as well as advanced genome editing, imaging and gene expression technologies are presenting their research. The symposium also covers novel strategies for regenerative medicine and transplantation.


Thursday, November 19, 2015

9.00 – 9.15 Welcome address

Ken Chien, Karolinska Institutet, Stockholm, Sweden, and Ulf de Faire/Jan Andersson, JIM

Chairperson: Ken Chien

9.15 – 10.00 Keynote Lecture: “Making pancreatic beta cells for diabetics”

Doug Melton, Harvard University, USA

Session 1: Genome Editing for Stem Cells and Regenerative Medicine

Chairperson: Timm Schroeder

10.00 – 10.30 “Development of genome editing using CRISPR-Cas systems”, Feng Zhang, Massachusetts Institute of Technology, USA

10.30 – 11.00 “Precision gene editing in nonhuman primates: approach to establishing human disease models” Weizhi Ji, Yunnan Key Laboratory of Primate Biomedical Research, China

11.00 – 11.30 “Generation of mammalian haploid embryonic stem cells”, Jinsong Li, SIBS, Shanghai, China


11.30 – 12.00 COFFEE BREAK


Session 2: Imaging and Lineage Tracing Technologies

Chairperson: Jinsong Li

12.00 – 12.30 “New developments in light microscopy”, Hjalmar Brismar, SciLifeLab, Karolinska Institutet, Stockholm, Sweden

12.30 – 13.00 “In vivo imaging, sensing and micro-manipultation”, Charles P. Lin, Massachusetts General Hospital, USA


13.00 – 14.00 LUNCH


14.00 – 14.30 “Life and death in patient-derived cancer organoids”, Hugo Snippert, University Medical Center, Utrecht, Netherlands

14.30 – 15.00 “Long-term single cell quantification: New tools for old questions”, Timm Schroeder, ETH, Basel, Switzerland


15.00 – 15.30 COFFEE BREAK


Session 3: The material-tissue interface in regenerative medicine

Chairperson: Ronald Li

15.30 – 16.00 “Translational regenerative medicine on trial”, Paolo Macchiarini, Karolinska Institutet, Stockholm, Sweden

16.00 – 16.30 “Designing biomaterials for regenerative medicine”, Molly Stevens, Imperial College, London, UK

Friday, November 20, 2015

Session 4: Differentiation of stem cells

Chairperson: May Griffith

9.00 – 9.30 “Single cell analysis of human pre-implantation embryos”, Fredrik Lanner, Karolinska Institutet, Stockholm, Sweden

9.30 – 10.00 “Naïve human ES cell derived mouse-human chimeras”, Jacob Hanna, Weizmann Institute Science, Israel

10.00 – 10.30 “New strategies for brain repair”, Malin Parmar, Lund University, Lund, Sweden


10.30 – 11.00 COFFEE BREAK


Session 5: Diseases and therapies I

Chairperson: Ernest Arenas

11.00 – 11.30 “Neural crest stem cells and Hirschsprung’s disease”, Paul Tam, University of Hong Kong, Hong Kong

11.30 – 12.00 “Stem cell therapy of liver disease”, Stephen Strom, Karolinska Institutet, Stockholm, Sweden

12.30 – 13.00 ”Genetic disease models and large-scale gene analysis through in utero nano-injection”, Emma Andersson, Karolinska Institutet, Stockholm, Sweden


13.00 – 14.00 LUNCH


Session 6: Diseases and therapies II

Chairperson: Paul Tam

14.00 – 14.30 “Prospect of new technologies in tissue engineering trachea”, Wei Wang SCMC, Shanghai, China

14.30 – 15.00 “High-biofidelity 3D human pluripotent stem cell-derived heart tissues and chambers for maturation, drug discovery and cardiotoxicity screening”, Ronald Li, University of Hong Kong, Hong Kong


15.00 – 15.30 COFFEE BREAK


15.30 – 16.00 “Regenerative approaches for the cornea”, May Griffith, Linköping University, Linköping, Sweden

16.00 – 16.30 “Novel neural in vitro models – from 3D cultures to organs-on-chips”, Anna Herland, Wyss Institute, Boston, USA

16.30 – 17.00 “Parkinson’s disease – regenerative approaches”, Ernest Arenas, Karolinska Institutet, Stockholm, Sweden

17.00 – 17.10 Concluding remarks, Urban Lendahl, Karolinska Institutet, Stockholm, Sweden

The symposium is open to the public on a “first-come, first-served” basis.

Regenerativ medicin